Minerva Endocrinology, published by EDIZIONI MINERVA MEDICA in Italy, serves as a pivotal platform for advancing knowledge in the field of endocrinology, diabetes, and metabolism. With its ISSN 2724-6507 and E-ISSN 2724-6116, the journal has rapidly established a reputable position in academia, achieving impressive rankings such as Q3 in both Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. This enables Minerva Endocrinology to attract a diverse readership, including researchers, healthcare professionals, and students committed to understanding the complexities of endocrine disorders. With annual publications covering breakthroughs and innovative research covering converged years from 2021 to 2024, the journal is devoted to facilitating the dissemination of high-quality studies that advance clinical and laboratory practices. Despite its >Open Access< status, the journal encourages submissions that reflect rigorous scientific inquiry and uphold the highest standards of scholarship, thereby enhancing its role as a significant contributor to the field of internal medicine and endocrinology.

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

Lancet Diabetes & Endocrinology is a premier peer-reviewed journal, published by Elsevier Science Inc, dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Established in 2013, this journal has quickly ascended to a position of notable prestige, reflected in its prestigious Q1 rank across various categories, including Endocrinology, Internal Medicine, and Diabetes & Metabolism. With an impressive impact factor and Scopus rankings placing it in the 99th percentile of its field, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal aims to disseminate high-quality research covering clinical and experimental aspects of metabolic and endocrine disorders, making it an indispensable tool for those looking to stay at the forefront of these rapidly evolving fields. With its focus on innovative depth and cutting-edge studies, Lancet Diabetes & Endocrinology continually fosters an international dialogue critical for advancements in diabetes and endocrinology.

Pituitary is a prominent academic journal dedicated to advancing the understanding of pituitary gland functions, disorders, and treatments within the sphere of Endocrinology, Diabetes, and Metabolism. Published by Springer in the Netherlands, this journal has established itself as a crucial resource for researchers and clinicians alike, as evidenced by its 2023 Category Quartiles ranking in Q2 and Q1, and a commendable Scopus ranking in both Medicine and Biochemistry. With a focus on innovative research and clinical advances, Pituitary covers a wide range of topics including hormone regulation, pituitary tumors, and endocrine therapies. While it does not currently offer Open Access options, the journal's rigorous peer-review process ensures that each article published contributes significantly to the scientific community's knowledge base. Researchers, professionals, and students will find Pituitary an invaluable resource for both current insights and ongoing developments in endocrine health.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

MOLECULAR AND CELLULAR ENDOCRINOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal resource in the fields of biochemistry, endocrinology, and molecular biology. With an ISSN of 0303-7207 and E-ISSN of 1872-8057, this esteemed journal has been disseminating significant findings since its inception in 1974 and continues to do so through 2024. Ranked in the Q1 quartile for Biochemistry and Q2 for both Endocrinology and Molecular Biology, it is recognized for its impactful contributions to research, holding impressive Scopus rankings that place it at the forefront of its category. The journal's wide-reaching influence is underscored by its commitment to quality, ensuring that only the most impactful articles advance the understanding of cellular mechanisms and hormonal regulation. Although not open-access, its relevance and rigorous peer-review process make it an essential read for researchers, professionals, and students eager to explore the complexities of endocrinology and biochemistry.

The Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.